Lupin signs MoU with Govt of Maharashtra to Combat Rising Prevalence of Cardiovascular Diseases

Lupin Human Welfare and Research Foundation (LHWRF) on Tuesday has signed a Memorandum of Understanding (MoU) with the Government of Maharashtra to address the growing prevalence of Cardiovascular Diseases (CVD) and Chronic Obstructive Pulmonary Disease (COPD) in the Palghar district of Maharashtra.

The partnership aims to prioritize the diagnosis and treatment of these diseases while working to reducing their long-term prevalence.

The program will be implemented over the next five years, initially focusing on two blocks, Palghar and Dahanu. The primary objectives include raising awareness about the risks associated with CVDs and COPD, highlighting the importance of early screening and diagnosis to prevent complications and decrease mortality rates.

The campaign will also promote healthy lifestyles and implement preventive measures, underscoring the significance of early screening, diagnosis and adherence to treatment.

Nilesh Gupta, Managing Director, Lupin says “As a leading healthcare provider, Lupin has consistently championed improved accessibility to high quality, cost-effective medicines for India’s marginalized and vulnerable communities.”

 “Through our collaborative efforts with state governments, we aim to strengthen existing healthcare systems and programs, focus on awareness, and enhancing quality, accessibility, and utilisation of healthcare services,” MD said.

To lay a strong foundation, an assessment study was conducted to map existing services, identify challenges in healthcare delivery, and estimate the cost-of-service gaps. The findings were reviewed by the Public Health Department (PHD) and incorporated into Lupin’s final program.

Source: Media reports

Related Blogs
blog-logo

Share Market

blog-logo

15 mins read . 08 Jul 2024

Best Oil & Gas Stocks in India

  • 0 people read
blog-logo

Share Market

blog-logo

11 mins read . 08 Jul 2024

How to Withdraw SIP Amount?

  • 0 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions